会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY
    • 具有细胞膜活化活性的肽
    • US20100168034A1
    • 2010-07-01
    • US12280077
    • 2007-02-20
    • Kyunglim LeeMoonhee KimMiyoung KimYoungjoo Kwon
    • Kyunglim LeeMoonhee KimMiyoung KimYoungjoo Kwon
    • A61K38/08C07K7/06C12N9/00C07H21/00A61P43/00
    • A61K47/64A61K47/65A61K48/0008C07K7/06C07K7/08C07K14/435C07K14/46C07K14/47C07K16/18
    • The present invention provides a peptide having cell membrane penetrating activity, a transmembrane carrier comprising the peptide having cell membrane penetrating activity as an effective component, a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance, a transfection kit comprising the peptide having cell membrane penetrating activity and the target substance, use of the peptide having cell membrane penetrating activity for the manufacture of a transmembrane complex, use of the transmembrane complex for the manufacture of a medicament, and a method for delivering a target substance into cell interior which comprises administrating to a subject with a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance to induce transduction of the transmembrane complex into cell interior. The peptide having cell membrane penetrating activity of the present invention has a prominent penetrating efficiency as compared with the activities of prior TAT-derived peptides and so the peptide has applications on intracellular delivery in various research fields as well as on therapeutics of specific diseases where targeting of drugs is required at high efficiency. Accordingly, the peptide having cell membrane penetrating activity, the transmembrane complex consisting of the peptide combined with a target substance and the method for delivering a target substance into cell interior using the transmembrane complex of the present invention are very useful as drug delivery systems.
    • 本发明提供具有细胞膜穿透活性的肽,包含具有细胞膜穿透活性的肽作为有效成分的跨膜载体,由具有与靶物质结合的细胞膜穿透活性的肽组成的跨膜复合物,包含 具有细胞膜穿透活性的肽和目标物质,具有细胞膜穿透活性的肽用于制造跨膜复合物的用途,跨膜复合物在制备药物中的用途以及将靶物质递送到 细胞内部,其包括用具有与靶物质组合的细胞膜穿透活性的肽组成的跨膜复合物施用于受试者,以诱导跨膜复合物进入细胞内部。 与先前的TAT衍生肽的活性相比,具有本发明的细胞膜穿透活性的肽具有突出的穿透效率,因此该肽可用于各种研究领域的细胞内递送以及针对特定疾病的治疗 的药物需要高效率。 因此,具有细胞膜穿透活性的肽,由靶物质结合的肽组成的跨膜复合物和使用本发明的跨膜复合物将靶物质输送到细胞内部的方法,作为药物递送系统是非常有用的。
    • 2. 发明授权
    • Deletion forms of IGE-dependent histamine releasing factor having histamine releasing activity, HRF-binding peptides and the uses thereof
    • 具有组胺释放活性的IGE依赖性组胺释放因子的缺失形式,HRF结合肽及其用途
    • US07772368B2
    • 2010-08-10
    • US11307141
    • 2006-01-25
    • Kyunglim LeeMiyoung Kim
    • Kyunglim LeeMiyoung Kim
    • C07K1/00
    • C07K14/52A61K38/00Y02A50/411Y02A50/473Y10S530/862Y10S530/868
    • The present invention relates to IgE-dependent histamine releasing factor (HRF) and HRF-binding peptides, more precisely, deletion forms of HRF which are able to be formed as dimers containing amino acid sequence represented by SEQ ID NO:3, genes encoding thereof and novel HRF-binding peptides having an activity of inhibiting HRF. The deletion forms of HRF which are able to be formed as dimers of the present invention induces intracellular secretion of histamine and IL-8, making an excellent candidate for a drug for inhibiting allergic reaction triggered by HRF and a kit for detecting HRF in serum of an allergy patient. In addition, novel HFR-binding peptides of the present invention bind to HRF to inhibit the actions of HFR, so they can be effectively used for the prevention and the treatment of allergic diseases of animals including asthma and rhinitis or malaria.
    • 本发明涉及IgE依赖性组胺释放因子(HRF)和HRF结合肽,更准确地说,能够形成为含有SEQ ID NO:3所示的氨基酸序列的二聚体的HRF的缺失形式,编码其的基因 和具有抑制HRF活性的新型HRF结合肽。 能够形成为本发明的二聚体的HRF的缺失形式诱导组胺和IL-8的细胞内分泌,成为用于抑制由HRF引发的过敏反应的药物和用于检测血清中HRF的试剂盒的优选候选物 过敏患者。 此外,本发明的新型HFR结合肽与HRF结合以抑制HFR的作用,因此它们可以有效地用于预防和治疗包括哮喘和鼻炎或疟疾在内的动物的过敏性疾病。